Picture of Carna Biosciences logo

4572 — Carna Biosciences News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Table: Garna Biosciences - 9-MTH group results

Nov 10 (Reuters)-  
             Garna Biosciences Inc  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 9 months ended      9 months ended        Year to   
                Sep 30, 2017        Sep 30, 2016      Dec 31, 2017   
                   LATEST             YEAR-AGO           LATEST      
                   RESULTS             RESULTS          FORECAST     
  Sales            483 mln             581 mln           701 mln     
                 (-16.8 pct)         (-54.5 pct)       (-13.5 pct)   
  Operating     loss 477 mln        loss 334 mln      loss 727 mln   
  Recurring     loss 486 mln        loss 352 mln      loss 738 mln   
  Net           loss 508 mln        loss 178 mln      loss 766 mln   
  EPS          loss 54.46 yen      loss 19.52 yen    loss 82.12 yen  
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
   
  NOTE - Garna Biosciences Inc.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T 
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Carna Biosciences

See all news